Zymeworks BC Inc

Zymeworks BC Inc

ZYME

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.73B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zymeworks BC IncZymeworks BC Inc-11.7--135%-0.4
$38.88

Target Price by Analysts

51.1% upsideZymeworks BC Target Price DetailsTarget Price
$-19.32

Current Fair Value

175.1% downside

Overvalued by 175.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.73 Billion
Enterprise Value$-145,193,069,311.00
Dividend Yield$- (-)
Earnings per Share$-1.08
Beta1.13
Outstanding Shares72,993,000

Return

Return on Equity-135.41%ROE
Return on Assets-27.41%
Return on Invested Capital-31.87%

Valuation & Multiples

P/E Ratio-11.65P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio0.02Price to Book Ratio
Enterprise Value to Revenue-57730.84
Enterprise Value to EBIT1.3
Enterprise Value to Net Income1
Total Debt to Enterprise-0.22
Debt to Equity0.4Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-0.56
Average shareholder expectation
Revenue Estimate
$4.54 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$2.53
Average shareholder expectation
Revenue Estimate
$212.49 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 12.72%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %12.36% 80.93%
Total Invested$240.52M 86.33%
Investors Holding66 155.00%

ESG Score

No data

About Zymeworks Inc

CEO: Ali Tehrani